OBLN Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (16 Jun 2021 @ 00:00):

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity...

Stats
Today's Volume	26.47M
Average Volume	1.51M
Market Cap	5.47M
EPS	$-0.000410 ( 2021-06-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.22
ATR14	$0.665 (21.80%)

Insider Trading

Date	Person	Action	Amount	type
2020-09-16	Stevenson Sharon	Buy	27 250	Stock Option (Right to Buy)
2020-09-16	Stevenson Sharon	Buy	27 250	Stock Option
2020-09-16	Dittamore Raymond V	Buy	27 250	Stock Option
2020-09-16	Dittamore Raymond V	Buy	27 250	Stock Option (Right to Buy)
2020-06-23	Hussainy Nooshin	Buy	165 135	Stock Option (Right to Buy)

INSIDER POWER
0.00
Last 98 transactions
Buy: 7 631 252 \| Sell: 41 791

Volume Correlation

Long: 0.21 (neutral)

Short: -0.67 (moderate negative)

Signal:(48.538) Neutral

Obalon Therapeutics Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Obalon Therapeutics Inc Correlation - Currency/Commodity

-0.65
( weak negative )

-0.80
( moderate negative )

-0.66
( moderate negative )

0.30
( neutral )

0.71
( moderate )

0.77
( moderate )

Obalon Therapeutics Inc Financials

Annual	2020
Revenue:	$1.59M
Gross Profit:	$584 000 (36.78 %)
EPS:	$-1.590

Q2	2021
Revenue:	$3 529.00
Gross Profit:	$2 153.00 (61.01 %)
EPS:	$-0.000413

Q1	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.440

Q4	2020
Revenue:	$61 000.00
Gross Profit:	$60 000.00 (98.36 %)
EPS:	$-0.170

Financial Reports:

No articles found.

Obalon Therapeutics Inc

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.